ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE

Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker. 本文中公开活性剂、含有其的组合物...

Full description

Saved in:
Bibliographic Details
Main Authors PROUDFOOT JOHN R, ALEXANDER JESSICA, BRIGGS TIMOTHY F, YASUDA KOJI, KIM MI-JEONG, SNEDEKER CHERI, AFRAND KAMALI SARVESTANI, TAYLOR STEVEN J, LIANG ANNA, NUDEL KATHLEEN, PECK SPENCER C, BUCKBINDER LEONARD, GUNASEKERA DINNARA, LANTER BERNARD, MASSARI FERDINAND E, LE DIANA, BERRY DAVID A, JOHN PATRICK JR CASEY
Format Patent
LanguageChinese
English
Published 12.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker. 本文中公开活性剂、含有其的组合物、含有其的单位剂型以及其使用方法,例如用于治疗代谢障碍或非酒精性脂肪性肝病或用于调节代谢标记物或非酒精性脂肪性肝病标记物。
Bibliography:Application Number: CN201980037671